期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

高效抗逆转录病毒疗法(HAART)相关线粒体毒性的研究进展 被引量：6

Progresses on HAART- related mitochondrial toxicities
下载PDF
导出
摘要 高效抗逆转录病毒疗法(HAART)是目前临床上最有效的治疗和控制艾滋病方法,HAART显著降低了艾滋病患者的死亡率,但部分患者可出现严重的毒副作用,最主要的毒副作用与线粒体毒性相关,本文就HAART导致线粒体损伤的相关机制进行综述。 Highly active antiretroviral therapy （HAART） is the most effective treating or controlling method of AIDS. HAART can significantly reduce the mortalities of AIDS patients. However, some severe side effects, which were mainly related to mitochondrial toxicity, appear during HAART. The mechanism of HAART-related mitochondrial toxicity was reviewed in this paper.
作者 陶思铮 李玉叶
机构地区 昆明医科大学第一附属医院皮肤性病科 云南省皮肤性病研究所
出处 《皮肤病与性病》 2014年第3期152-154,共3页 Dermatology and Venereology
基金 云南省科学技术厅项目(2010CD153 2011CI046) 云南省卫生厅项目(D-201234)
关键词 艾滋病 线粒体 高效抗逆转录病毒治疗 毒副作用 AIDS Mitoehondrion Highly active antiretroviral therapy （HAART） Side effect
分类号 R512.91 [医药卫生—内科学]
  • 相关文献

参考文献20

  • 1Walker BD, Hirsch MS. Antiretroviral Therapy in Early HIV Infection [J]. NEnglJMed, 2013, 368(3) : 279-281. 被引量：1
  • 2谢静,李太生.艾滋病抗病毒治疗新药的研究进展[J].中国艾滋病性病,2008,14(6):631-633. 被引量：10
  • 3Edeas M,Attaf D, Mailfert AS, et al. Maillard reaction, mitochondria and oxidative stress: potential role of antioxidants [ J ]. Pathol Biol (Paris) , 2010, 58(3) : 220-225. 被引量：1
  • 4Monnot S, Samuels DC, Hesters L, et al. Mutation dependance of the mitochondrial DNA copy number in the first stages of human embryo- genesis [J]. Hum Mol Genet, 2013, 22(9) : 1867-1872. 被引量：1
  • 5Sovari AA, Rutledge CA, Jeong EM, et ah Mitoehondria Oxidative stress, connexin43 remodeling, and sudden arrhythmie death [ J]. Cire Arrhythmia Elec, 2013, 6(3) : 623-631. 被引量：1
  • 6Irvin MR, Shrestha S, Chen YD, et al. Genes linked to energy me- tabolism and immunoregulatory mechanisms are associated with subcu-taneous adipose tissue distribution in HIV-infected men [J]. Pharma- cogenet Genomics, 2011, 21 (12): 798-807. 被引量：1
  • 7Lin CH, Sloan DD, Dang CH, et al. Assessment of mitochondrial tox- icity by analysis of mitochondrial protein expression in mononuelear cells [ J ]. Cytometry B Clin Cytom, 2009, 76 (3) : 181 - 190. 被引量：1
  • 8Lewis W, Kohler JJ, Hosseini SH, et al. Antiretroviral nucleosides, deoxynucleotide carrier and mitochendrial DNA: evidence supporting the DNA pol gamma hypothesis [ J ]. AIDS, 2006, 20 ( 5 ) : 675 -684. 被引量：1
  • 9Apostolova N, Blas-Gareia A, Esplugues JV. Mitoehondfial interfer- ence by anti-HIV drugs: mechanisms beyond Pol-γ inhibition [ Jl. Trends Pharmacol Sci, 2011, 32(12) : 715-725. 被引量：1
  • 10Payne BA, Wilson IJ,Hateley CA, et al. Mitochondrial aging is ac- celerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations [J]. Nat Genet, 2011,43(8) : 806-810. 被引量：1

二级参考文献24

  • 1Autran B, Carcelain G, Li TS, et al.Positive effects of combined antiretroviral therapy on CD4^+ T cell homeostasis and function in advanced HIV disease[J]. Science, 1997,277(5322 : 112 - 116. 被引量：1
  • 2Li TS, Tubiana R, Katlama C, et al. Long-lasting recovery in CD4^+ T cell function and viral load reduction after highly active antiretroviral therapy in advanced HIV disease[ J ]. Lancet, 1998,351 (9117) : 1682 -1686. 被引量：1
  • 3Miller M ,Witmer M, Stillmock K, et al. Biochemical and antiviral activity of MK-O518,a potent HIV integrase inhibitor[C]. 16th International AIDS Conference; Toronto, Canada, Aug 13 - 18 2006. Abstract THAA0302. 被引量：1
  • 4Hazuda DJ, Felock P, Witmer M, et al. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells[J]. Science,2000,287(5453) :646 - 650. 被引量：1
  • 5Markowitz M, Nguyen BY, Gotuzzo E, et al. Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study[J]. J Acquir Immune Defic Syndr,2007,46(2) : 125 - 133. 被引量：1
  • 6Grinsztejn B, Nguyen BY, Katlama C, et al, Safety and efficacy of the HIV-1 integrase inhibitor raltegravir(MK-0518)in treatment-experienced patients with multidrug-resistant virus: a phase Ⅱ randomised controlled trial[ J ] . Lancet, 2007,369 ( 9569 ) : 1261 - 1269. 被引量：1
  • 7Cooper D, Gatell J, Rockstroh J, et al. 48-week results from BENCHMRK - 1 ,a phase Ⅲ study of raltegravir in patients failing ART with triple-class resistant HIV-1 [ C]. The 15th Conference on Retroviruses ans Opportunistic Infections. Boston, 2008, Abstract 788. 被引量：1
  • 8Steigbigel R, Kumar P, Eron J, et al. 48-week results from BENCHMRK-2 ,a phase Ⅲ study of raltegravir in patients failing ART with triple-class resistant HIV-1 [ C]. The 15th Conference on Retroviruses and Opportunistic Infections. Boston,2008, Abstract 789. 被引量：1
  • 9DeJesus E, Berger D, Markowitz M, et al. Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS- 9137 (JTK-303) in treatment-naive and treatment-experienced patients [J].J Acquir Immune Defic Syndr,2006,43(1) :1-5. 被引量：1
  • 10Zolopa AIR, Mullen M, Berger D, et al. The HIV Integrase Inhibitor GS-9137 Demonstrates Potent Antiretroviral Activity in Treatmentexperienced Patients[C] .The 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles,2007,Abstract 143LB. 被引量：1

共引文献9

同被引文献80

引证文献6

二级引证文献35

皮肤病与性病
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部